These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 23922874
1. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. Zhang C, Tong J, Huang G. PLoS One; 2013; 8(7):e69963. PubMed ID: 23922874 [Abstract] [Full Text] [Related]
2. MicroRNA-26b Reduces Cell Viability by Inhibition of Nicotinamide Phosphoribosyltransferase in Breast Cancer Cells. Ameli Mojarad M, Ameli Mojarad M, Pourmahdian A. DNA Cell Biol; 2022 Aug; 41(8):735-741. PubMed ID: 35792597 [Abstract] [Full Text] [Related]
4. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells. Hesari Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, Alipour M, Tavakoli-Yaraki M, Ghorbanhosseini SS, Yousefi Z, Jafarzadeh M, Yarahmadi S. Gene; 2018 Oct 05; 673():149-158. PubMed ID: 29886033 [Abstract] [Full Text] [Related]
12. Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells. Ogino Y, Sato A, Kawano Y, Aoyama T, Uchiumi F, Tanuma SI. Anticancer Res; 2019 Dec 31; 39(12):6457-6462. PubMed ID: 31810909 [Abstract] [Full Text] [Related]
15. Up-regulation of miR-381 inhibits NAD+ salvage pathway and promotes apoptosis in breast cancer cells. Bolandghamat Pour Z, Nourbakhsh M, Mousavizadeh K, Madjd Z, Ghorbanhosseini SS, Abdolvahabi Z, Hesari Z, Mobaser SE. EXCLI J; 2019 Dec 31; 18():683-696. PubMed ID: 31611752 [Abstract] [Full Text] [Related]
16. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. Li Y, Sun Z, Liu B, Shan Y, Zhao L, Jia L. Cell Death Dis; 2017 Jun 22; 8(6):e2892. PubMed ID: 28640257 [Abstract] [Full Text] [Related]
17. NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP. Lucena-Cacace A, Otero-Albiol D, Jiménez-García MP, Muñoz-Galvan S, Carnero A. Clin Cancer Res; 2018 Mar 01; 24(5):1202-1215. PubMed ID: 29203587 [Abstract] [Full Text] [Related]
18. Overexpression of miR-182 inhibits ossification of ligamentum flavum cells by targeting NAMPT. Zhang Q, Shen Y, Jiang Y, Zhao S, Zhou D, Xu N. Exp Cell Res; 2018 Jun 15; 367(2):119-131. PubMed ID: 29601800 [Abstract] [Full Text] [Related]
19. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells. Tan B, Dong S, Shepard RL, Kays L, Roth KD, Geeganage S, Kuo MS, Zhao G. J Biol Chem; 2015 Jun 19; 290(25):15812-15824. PubMed ID: 25944913 [Abstract] [Full Text] [Related]
20. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J. Mol Med; 2013 Feb 08; 18(1):1491-8. PubMed ID: 23255074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]